MetAlert Completes Corporate Actions and Retains North Equities Corp for Digital Marketing Services
LOS ANGELES CALIFORNIA, October 20, 2022, MetAlert, Inc. (OTC: MLRT), a pioneer in the field of health & safety, wearable GPS human and asset tracking systems, announced it has received final approval from the regulatory bodies and completed all of the corporate actions filed in their 14c on July 19. MetAlert, Inc., formerly known as GTX Corp, is now operating and trading under its new ticker symbol MLRT.
As part of its marketing strategy, MetAlert, has also retained North Equities Corp to provide digital marketing services aimed at building awareness of its rebranding and positioning in the medical device, telehealth, and remote patient monitoring (RPM) industry.
Patrick Bertagna, MetAlert CEO, commented on this development by saying, “We believe that North Equities brings unique skills and expertise that will help strengthen our existing team, as we continue to grow and build recognition in the marketplace. We are excited about the possibilities that lie ahead and with our team’s expertise in digital marketing and keen focus on strategic brand building, we look forward to achieving great things in the future as we navigate the ever-changing markets of today.”
Since the rebranding went effective MetAlert has received a significant amount of media coverage both domestically and internationally. The Company was mentioned in dozens of U.S. media outlets including FOX News, ABC News, CBS News, NBC News, Yahoo Finance, NY Business Digest, PubCo Insights, Belmont Star, Herald Market and Security Solutions Watch. Internationally, MetAlert news was reported in Mexico, Canada, Japan, India, Thailand, Brazil, Germany, and New Zealand.
Link to the recent MetAlert Media Coverage Index.
Recent Stock Day Podcast Interview
Revolutionizing Investment: Mobi Card's Game-Changing Updates – Stock Day Media
The Company has several scheduled interviews in the coming weeks and will continue its media campaign to increase brand awareness for MetAlert and explain its broader vison centered around solutions that improve health, safety, wellness, longevity, and quality of life.
For all press or sales inquiries, please contact us at info@metalert.com
MetAlert (OTC: MLRT) and its subsidiaries occupy a commanding position in the design, development, manufacturing, distribution, sales, and licensing of GPS wearable technology, asset recovery services, wandering assistive technology, and health data collection and monitoring. The Company delivers comprehensive global solutions encompassing logistics, hardware, software, and connectivity.
Notable achievements include GunAlert the world’s first all in one firearm safety solution gun lock with patented motion sensor and GPS theft recovery. And the groundbreaking GPS SmartSole®, a fusion of Dr. Scholl’s comfort with LoJack’s tracking prowess. It stands as the world’s inaugural invisible wearable tracking device, designed for individuals susceptible to wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based model thrives on technology innovation fortified by intellectual property safeguards. The company boasts international distribution channels serving customers across 40 countries, alongside its role as a U.S. Military Government contractor. In addition to public health entities, MetAlert caters to municipalities, emergency and law enforcement agencies, private educational institutions, assisted living facilities, NGOs, senior care residences, consumers, and small enterprises.
General information, investor relations, wholesale licensing, consumer purchase:
213.489.3019 | Info@MetAlert.com | IR@MetAlert.com | Contact Us
MetAlert.com | Mygunalert.com | Track My Workforce | GPS SmartSole.com
MetAlert United Kingdom– In the UK, MetAlert operates from its London office.
Please contact: Nelson Skip Riddle | Email: NSRiddle@MetAlert.com | Tel: +44 7785 364100
Level 2 Security (Wholly owned subsidiary) Email: contactus@level2sec.com | www.mygunalert.com | www.ifitmoves.com
Forward Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document’s content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.